Start your intake Understanding Remedy Meds and Henry Meds as Telehealth Models Remedy Meds operates as a direct-to-consumer telehealth platform offering compounded and branded GLP-1 options through a network of licensed prescribers
While the Retatrutide weight loss potential is significant, it remains in the clinical trial phase and is not yet FDA approved
Increased Confidence Smart ESCs function like a virtual engineer inside your model
If you plateau after 1216 weeks, your PlexusDx provider can assess whether you'd benefit from dose increase, compound switch, or genetic testing to understand your individual peptide pathway response and unlock further progress
GLPs and Weight Loss: Why Fast, Accurate Testing Matters
Assessing potential eye health risk from GLP-1 medications The Potential Risks of GLP-1 Agonists and Semaglutide to Eye Health In recent years, GLP-1 agonists, such as semaglutide (commonly marketed under names like Ozempic and Wegovy), have gained widespread popularity for their ability to help with weight loss and manage type 2 diabetes
